Related Experiment Video
Updated: Mar 11, 2026

07:48
Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
Published on: June 8, 2019
9.3K
Prolonged Fasting Improves Endothelial Progenitor Cell-Mediated Ischemic Angiogenesis in Mice
Bao Xin1, Chun-Long Liu, Hong Yang
1Department of Identification of Traditional Chinese Medicine, The Second Military Medical University, Shanghai, China.
Summary
Prolonged fasting (PF) enhances endothelial progenitor cell (EPC) function, promoting angiogenesis and reducing stroke injury in mice. This suggests PF may be a novel therapeutic strategy for ischemic vascular diseases.
Area of Science:
- Vascular biology and regenerative medicine
- Neuroscience and cerebrovascular research
- Metabolic health and disease
Background:
- Prolonged fasting (PF) is recognized for its health benefits, including chronic disease risk reduction.
- Endothelial progenitor cells (EPCs) play a crucial role in repairing damaged blood vessels and promoting angiogenesis.
- Cerebral ischemic injury, a major cause of stroke, involves impaired blood flow and neuronal damage.
Purpose of the Study:
- To investigate the impact of prolonged fasting (PF) on endothelial progenitor cell (EPC)-mediated angiogenesis.
- To determine the effect of PF on cerebral ischemic injury in a mouse model.
- To explore the therapeutic potential of PF in treating ischemic vascular diseases.
Main Methods:
- Mice underwent prolonged fasting (PF) or periodic PF following induced cerebral ischemia.
- Histological analysis and behavioral tests were conducted to assess brain injury and function.
- Mouse EPCs were isolated, characterized, and their transplantation effects on cerebral ischemia were evaluated.
Main Results:
- PF significantly enhanced EPC function and angiogenesis in the ischemic brain, reducing cerebral ischemic injury.
- Periodic PF improved long-term neurobehavioral outcomes and reduced cortical atrophy in mice.
- EPCs from PF-treated mice exhibited increased eNOS, MnSOD, and NO levels, with reduced TSP-2 and O2- levels, demonstrating improved angiogenic and protective capabilities.
Conclusions:
- Prolonged fasting promotes EPC-mediated ischemic angiogenesis and improves long-term stroke outcomes in mice.
- PF enhances the therapeutic potential of EPCs for treating ischemic vascular conditions.
- PF emerges as a promising, non-pharmacological intervention for ischemic vascular diseases.

